At a glance
ClinicalIndex Comparison Record- ✓FQHC implementation team staff in the intervention facilities
- ✓Lung screening partners of the intervention FQHCs
- ✕FQHC staff or partners who leave the organization before the end of the study
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Systematic Approach to Designing an Implementation Strategy to Increase Lung Cancer Screening and Smoking Cessation Treatment Among Federally Qualified Community Health Center Patients Who Smoke
In Brief
A clinical study evaluating Qualitative Group Interviews and Stakeholder advisory group for Smoking Cessation. Completed, enrolled 9 participants across 1 site.
Detailed Summary
Tobacco use is the leading preventable cause of death in the US and a major driver of health disparities. Among our tools for reducing the harms of tobacco is lung cancer screening (LCS). This study will combine a review of existing qualitative and quantitative data on barriers to lung cancer screening and smoking cessation in underserved populations, a quantitative analysis of predictors of lung cancer screening and smoking cessation treatment use among Massachusetts Federally Qualified Health Centers (FQHC)s, and a stakeholder advisory group to synthesize these data and select implementation strategies that reflects the critical determinants and the strengths and resource constraints of the Federally Qualified Health Centers (FQHC) context.
Study Details
Timeline
Interventions
One time interview, 60-90 minutes
The team will meet with the stakeholder advisory group four times for 1-2 hours each